98%
921
2 minutes
20
Previous studies by our group have shown that Sb(V) is able to enter red blood cells in a dynamic process and is reduced to Sb(III) by glutathione. The present study aims to investigate a possible entry pathway for Sb(V) through the erythrocyte membrane. Applying fluorescence spectroscopy studies with Laurdan and diphenylhexatriene (DPH) probes, it was found that there was no interaction between Sb(V) and membrane lipids. By comparing the Sb(V) entry percentages through lipid vesicles and sealed erythrocyte membranes, it was found that Sb(V) required protein channels to pass through the membrane. The competitive inhibition results using HCO3 (-) and Cl(-) showed that the Sb(V) uptake rate through the membrane fell approximately 50-70 % until full inhibition was reached, which was possibly due to the inhibition of the anion exchanger 1 (AE1) channel. Finally, the fluorescence measurements with the 5-iodoacetamidofluorescein (5-IAF) probe showed that Sb(V) interacted with membrane protein SH groups during this process.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00216-015-9188-y | DOI Listing |
Stomatin is a ubiquitous and highly expressed protein in erythrocytes, which associates with cholesterol-rich microdomains in the plasma membrane and is known to regulate the activity of multiple ion channels and transporters, but the structural basis of association with stomatin targets remains unknown. Here we describe high-resolution structures of multiple stomatin complexes with endogenous binding partners isolated from human erythrocyte membranes, revealing that stomatin specifically associates with two membrane proteins involved in water transport and cell volume regulation, aquaporin-1 (AQP-1) and the urea transporter, UT-B (SLC14A1). Together, our results reveal the structural basis of stomatin oligomerization, membrane association, and target recruitment, and identify a putative role for stomatin in the regulation of osmotic balance in the erythrocyte.
View Article and Find Full Text PDFRinsho Ketsueki
September 2025
Department of Hematology, Kawasaki Medical School.
Warm autoimmune hemolytic anemia (wAIHA) is an autoimmune disorder in which autoantibodies target the patient's own red blood cells. It can be classified as either idiopathic (primary) or secondary and is characterized by the presence of pan-reactive immunoglobulin G (IgG) autoantibodies that recognize epitopes on erythrocyte membrane proteins such as band 3 and Rh polypeptides. Spontaneous remission is rare, and corticosteroids are commonly used as first-line therapy.
View Article and Find Full Text PDFColloids Surf B Biointerfaces
August 2025
Department of Urology, the First Hospital of Jilin University, Changchun 130021, PR China. Electronic address:
Chemotherapy remains a cornerstone treatment for advanced prostate cancer. Nano drug delivery systems have revolutionized targeted therapy by overcoming challenges such as poor water solubility, lack of specificity, and the side effects associated with conventional drugs. However, the rapid clearance and immunogenicity of nanoparticles limit their in vivo efficacy.
View Article and Find Full Text PDFCinnamaldehyde is a natural compound known for its antimicrobial and anticancer properties. Fourteen novel cinnamaldehyde-chalcone analogues (5a-5n) were synthesized and evaluated for anti-cancer, anti-bacterial, and anti-fungal activities. Among these, bromoethane chalcone 5n exhibited significant cytotoxicity against DU145 (IC50: 8.
View Article and Find Full Text PDFBr J Nutr
August 2025
Department of Nutrition, School of Public Health, University of São Paulo, São Paulo, Brazil.
The -3 index has been proposed as a risk factor for CVD endpoints. However, the association of the O3I defined with different cut-offs and cardiometabolic risk factors has been less studied. This study aimed to investigate the association between two cut-off points of the O3I and cardiometabolic risk factors in Brazilian and Puerto Rican adults.
View Article and Find Full Text PDF